Circulating FABP-4 Levels in Patients with Atherosclerosis or Coronary Artery Disease: A Comprehensive Systematic Review and Meta-Analysis.
Narges JalilianReza PakzadMahdi ShahbaziSeyyed-Reza EdrisiKarimeh HaghaniMohsen JalilianSalar BakhtiyariPublished in: Cardiovascular therapeutics (2023)
In summary, this meta-analysis revealed elevated circulating FABP-4 levels in CDs, suggesting its potential as a biomarker for these conditions. Further research is warranted to explore its clinical relevance.